These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29454961)

  • 21. Management of and risk factors related to hepatotoxicity during tuberculosis treatment.
    Babalık A; Arda H; Bakırcı N; Ağca S; Oruç K; Kızıltaş S; Cetintaş G; Calışır HC
    Tuberk Toraks; 2012; 60(2):136-44. PubMed ID: 22779934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antituberculosis drugs and hepatotoxicity.
    Sharma SK
    Infect Genet Evol; 2004 Jun; 4(2):167-70. PubMed ID: 15157635
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatic functional changes induced by the combined use of isoniazid, pyrazinamide and rifampicin in the treatment of pulmonary tuberculosis].
    de Souza AF; de Oliveira e Silva A; Baldi J; de Souza TN; Rizzo PM
    Arq Gastroenterol; 1996; 33(4):194-200. PubMed ID: 9302332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global Urine Metabolomics in Patients Treated with First-Line Tuberculosis Drugs and Identification of a Novel Metabolite of Ethambutol.
    Das MK; Arya R; Debnath S; Debnath R; Lodh A; Bishwal SC; Das A; Nanda RK
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2257-64. PubMed ID: 26833163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Side effects of drugs used to treat tuberculosis.
    Newton RW
    Scott Med J; 1975 Mar; 20(2):47-9. PubMed ID: 47648
    [No Abstract]   [Full Text] [Related]  

  • 26. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the farnesoid X receptor in quadruple anti-tuberculosis drug-induced liver injury.
    Wen Y; Zhang G; Wu X
    Toxicology; 2022 Jun; 476():153256. PubMed ID: 35835356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
    Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The best approach to reintroducing tuberculosis treatment after hepatotoxicity is still open to debate.
    Chang KC; Leung CC
    Clin Infect Dis; 2010 Aug; 51(3):366-7; author reply 367-8. PubMed ID: 20597681
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.
    Sharma SK; Singla R; Sarda P; Mohan A; Makharia G; Jayaswal A; Sreenivas V; Singh S
    Clin Infect Dis; 2010 Mar; 50(6):833-9. PubMed ID: 20156055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolomic Study to Determine the Mechanism Underlying the Effects of
    Ke XH; Wang CG; Luo WZ; Wang J; Li B; Lv JP; Dong RJ; Ge DY; Han Y; Yang YJ; Tu-Erxun RY; Liu HS; Wang YC; Liao Y
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide.
    Lin HS; Cheng CW; Lin MS; Chou YL; Chang PJ; Lin JC; Ye JJ
    Clin Interv Aging; 2016; 11():299-306. PubMed ID: 27042029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Secular increase in the incidence rate of drug-induced hepatitis due to anti-tuberculosis chemotherapy including isoniazid and rifampicin].
    Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H; Mohri M
    Kekkaku; 2003 Apr; 78(4):339-46. PubMed ID: 12739393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatotoxic effects of tuberculosis therapy. A practical approach to a tricky management problem.
    Ali J
    Postgrad Med; 1996 May; 99(5):217-20, 230-1, 235-6. PubMed ID: 8650087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urine metabolomics and microbiome analyses reveal the mechanism of anti-tuberculosis drug-induced liver injury, as assessed for causality using the updated RUCAM: A prospective study.
    Wang MG; Wu SQ; Zhang MM; He JQ
    Front Immunol; 2022; 13():1002126. PubMed ID: 36483548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: a preliminary report.
    Saigal S; Agarwal SR; Nandeesh HP; Sarin SK
    J Gastroenterol Hepatol; 2001 Sep; 16(9):1028-32. PubMed ID: 11595068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of ABCC Gene Polymorphism With Susceptibility to Antituberculosis Drug-Induced Hepatotoxicity in Western Han Patients With Tuberculosis.
    Bai H; Wu T; Jiao L; Wu Q; Zhao Z; Song J; Liu T; Lv Y; Lu X; Ying B
    J Clin Pharmacol; 2020 Mar; 60(3):361-368. PubMed ID: 31648372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifampin plus pyrazinamide-induced hepatitis requiring hospitalization in a 30-y-old male with latent tuberculosis.
    Potolidis E; Mantadakis E; Zeniodi MH; Samonis G
    Scand J Infect Dis; 2005; 37(2):155-7. PubMed ID: 15773037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug lymphocyte stimulation test in the diagnosis of adverse reactions to antituberculosis drugs.
    Suzuki Y; Miwa S; Shirai M; Ohba H; Murakami M; Fujita K; Suda T; Nakamura H; Hayakawa H; Chida K
    Chest; 2008 Nov; 134(5):1027-1032. PubMed ID: 18583516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid peroxidation aggravates anti-tuberculosis drug-induced liver injury: Evidence of ferroptosis induction.
    Pan Y; Tang P; Cao J; Song Q; Zhu L; Ma S; Zhang J
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1512-1518. PubMed ID: 33121683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.